Histologic differentiation, cancer volume, and pelvic lymph node metastasis in adenocarcinoma of the prostate.
about
Assessment of morphometric measurements of prostate carcinoma volumeMicrovascularity in transition zone prostate tumors resembles normal prostatic tissue.The Gordon Wilson Lecture. Natural history and treatment of early stage prostate cancer.Significance of predicted tumor volume as a predictor of pathologic stage in patients undergoing radical prostatectomy.Prognostic markers in prostate cancer.The role of MRI in prostate cancer active surveillance.Biologic differences between peripheral and transition zone prostate cancerDifferent phenotypes in human prostate cancer: alpha6 or alpha3 integrin in cell-extracellular adhesion sitesNatural history of small index lesions suspicious for prostate cancer on multiparametric MRI: recommendations for interval imaging follow-up.Original and infiltrating patterns of prostatic carcinomaWhole-lesion apparent diffusion coefficient metrics as a marker of percentage Gleason 4 component within Gleason 7 prostate cancer at radical prostatectomy.Patients treated with radical prostatectomy with positive digital rectal examination findings in the intermediate-risk group are prone to PSA recurrenceProstate tumor volume measurement with combined T2-weighted imaging and diffusion-weighted MR: correlation with pathologic tumor volume.Comparison of 68Ga-HBED-CC PSMA-PET/CT and multiparametric MRI for gross tumour volume detection in patients with primary prostate cancer based on slice by slice comparison with histopathology.Concordance between transrectal ultrasound guided biopsy results and radical prostatectomy final pathology: Are we getting better at predicting final pathology?Lymph node-positive prostate cancer: current issues, emerging technology and impact on clinical outcome.Nationwide prevalence of lymph node metastases in Gleason score 3 + 3 = 6 prostate cancer.Baseline and Longitudinal Plasma Caveolin-1 Level as a Biomarker in Active Surveillance for Early Stage Prostate Cancer.Functional magnetic resonance imaging and molecular pathology at the crossroad of the management of early prostate cancer.Prostate cancer: from Gleason scoring to prognostic grade grouping.Is there a difference in outcome after radical prostatectomy between patients with biopsy Gleason sums 4, 5, and 6? Results from the SEARCH database.Histopathology of Prostate Cancer.Watchful waiting or watchful progression?: Prostate specific antigen doubling times and clinical behavior in patients with early untreated prostate carcinoma.Prospective study of cancer detection in black and white men with normal digital rectal examination but prostate specific antigen equal or greater than 4.0 ng/mL.The diagnosis and reporting of adenocarcinoma of the prostate in core needle biopsy specimens.Pre-neoplastic lesions of the prostate.The elevated expression of a mismatch repair protein is a predictor for biochemical recurrence after radical prostatectomy.Does the Prostate Health Index Depend on Tumor Volume?-A Study on 196 Patients after Radical Prostatectomy.Association of prostate-specific antigen promoter genotype with clinical and histopathologic features of prostate cancerPretreatment tumor volume estimation based on total serum psa in patients with localized prostate cancer.Tumour angiogenesis in latent prostatic carcinoma.Markovian model of growth and histologic progression in prostate cancer.Targeted Biopsy to Detect Gleason Score Upgrading during Active Surveillance for Men with Low versus Intermediate Risk Prostate Cancer.Gleason 5+4 has worse oncological and pathological outcomes compared with Gleason 4+5: significance of Gleason 5 pattern.Preoperative multiparametric MRI of the prostate for the prediction of lymph node metastases in prostate cancer patients treated with extended pelvic lymph node dissection.Prognostic value of bone sialoprotein expression in clinically localized human prostate cancer.Chromosome 16q24 deletion and decreased E-cadherin expression: possible association with metastatic potential in prostate cancer.Prostate cancer glands with cribriform architecture and with glomeruloid features should be considered as Gleason pattern 4 and not pattern 3.Prognostic significance of histologic grading in patients with prostate carcinoma who are assessed by the Gleason and World Health Organization grading systems in needle biopsies obtained prior to radiotherapy.Unilateral positive biopsies in low risk prostate cancer patients diagnosed with extended transrectal ultrasound-guided biopsy schemes do not predict unilateral prostate cancer at radical prostatectomy.
P2860
Q28364810-50DEBCF4-DB53-4A7F-AA4E-BFBF38B430BEQ31097312-0E9AFAAE-E22A-4B16-B7A4-92774E2678DCQ33958709-430E41F6-1B25-4A20-AD3D-243B183E4AABQ34567883-8BE07277-29D7-4134-83E1-341803C2D0ABQ34606318-8A86CC2B-830F-4437-B054-724437E48DC7Q34705261-4FB3F32E-AD00-4965-B7E4-1FE9640E112EQ34734506-BA24A9E5-1480-4919-B10C-210C28DFA670Q34929028-B031493E-7D4D-4E37-A209-51EF674622EAQ35720507-94EC85BD-7EE7-4B7D-844E-786068F36207Q36216705-071A953B-EEC4-4840-B0F9-508804EB99BAQ36417640-47C1F776-1043-4A13-9B88-93FC69D522D3Q36954643-6A73146C-A650-490F-9C0B-2811088B2485Q37366891-19C031DC-0D77-48DC-B9B4-5BE3B4069ED2Q37541876-C655D9D5-73FB-496A-86B9-433489F6C0CBQ37593740-A36369C0-ECAC-4190-BA0E-20579C4A145FQ37934976-20A7A9B1-3480-4D72-971E-B58B46280CB7Q38209526-3CB9D296-BA43-4114-B588-9CDE0701BBDFQ38373132-6809560E-6618-44CA-A6F7-9FCC299977F1Q38461592-47CF2A7E-8B40-4462-AFBB-13D10AB3BB43Q38786316-34DC6687-7E23-4F0F-9DC6-5BDE356DBE1EQ39219786-7694FE30-699F-4A06-BE01-74A13EEE8161Q39227648-63C9D580-B69E-4905-8BC6-54999F9F6DEBQ39459344-7260F318-2532-4E10-9FE8-BA9873A73A0BQ39598020-E58C3EE4-BB24-4CD7-8E1D-F8C8E74EF113Q41010834-66AC1FA7-1E87-4A2E-BE3F-18427ADD7CE6Q41144382-5ECCE85C-39BF-4E2F-BA7E-6787047FF190Q41829002-15CA825A-9BF8-40EC-825F-3015B81AF6E2Q41837254-2C816ECA-BB83-4FEE-ADE4-BD2821DFCC6EQ41908642-65A85A9D-788D-40EE-A6A9-927FFBF54FA1Q42007793-812D310D-2C6D-418A-B84C-916A3085D4E3Q42020401-E574B470-285D-4A05-9B4C-6D5551E6A1ABQ44078760-8268B13B-71F9-4645-8957-F6746A0B384CQ44607269-F80B7E10-F37E-4CFA-90F7-9696D1862FE3Q44745051-92E22C92-EC37-47EB-95A3-6B1D42CBB8CFQ47261973-5F735C68-D30B-4604-89DA-C7EEFD99DAD4Q47842199-716D39B8-4E6E-44B0-8F7F-9E9690271594Q47893936-D4B8F81E-C49B-413E-9C79-65AC4AE2778CQ48108186-57136560-7BCC-49B1-AC58-1C3A8A5E4177Q51064511-E307594C-4F1E-4AC8-91C7-6571B0D93CDDQ53091492-A411E694-57BF-47E1-8E43-B56E97D21A61
P2860
Histologic differentiation, cancer volume, and pelvic lymph node metastasis in adenocarcinoma of the prostate.
description
1990 nî lūn-bûn
@nan
1990年の論文
@ja
1990年学术文章
@wuu
1990年学术文章
@zh
1990年学术文章
@zh-cn
1990年学术文章
@zh-hans
1990年学术文章
@zh-my
1990年学术文章
@zh-sg
1990年學術文章
@yue
1990年學術文章
@zh-hant
name
Histologic differentiation, ca ...... denocarcinoma of the prostate.
@en
Histologic differentiation, ca ...... denocarcinoma of the prostate.
@nl
type
label
Histologic differentiation, ca ...... denocarcinoma of the prostate.
@en
Histologic differentiation, ca ...... denocarcinoma of the prostate.
@nl
prefLabel
Histologic differentiation, ca ...... denocarcinoma of the prostate.
@en
Histologic differentiation, ca ...... denocarcinoma of the prostate.
@nl
P2093
P1433
P1476
Histologic differentiation, ca ...... denocarcinoma of the prostate.
@en
P2093
P304
P356
10.1002/1097-0142(19900915)66:6<1225::AID-CNCR2820660624>3.0.CO;2-X
P407
P577
1990-09-01T00:00:00Z